Last reviewed: November 2017
Last updated: November  2017

Summary

Definition

History and exam

Key diagnostic factors

  • storage symptoms
  • voiding symptoms

Other diagnostic factors

  • fever with dysuria
  • urinary retention

Risk factors

  • age over 50 years
  • family history
  • non-Asian race
  • cigarette smoking
  • male pattern baldness
  • metabolic syndrome

Diagnostic investigations

1st investigations to order

  • urinalysis
  • PSA
  • American Urological Association (AUA) symptom score
  • global bother score
  • volume charting
Full details

Investigations to consider

  • ultrasound
  • CT abdomen/pelvis
  • cystoscopy
  • uroflowmetry
  • urodynamic study
Full details

Treatment algorithm

Contributors

Authors VIEW ALL

Michael T. Flannery

Professor and Program Director

Internal Medicine Residency

University of South Florida College of Medicine

Department of Internal Medicine

Tampa

FL

Disclosures

MTF declares that he has no competing interests.

Assistant Professor and Program Director

Internal Medicine-Pediatrics Residency

University of South Florida College of Medicine

Department of Internal Medicine

Tampa

FL

Disclosures

EA declares that she has no competing interests.

Peer reviewers VIEW ALL

Consultant Urological Surgeon

Royal Hallamshire Hospital

Honorary Senior Lecturer of Urology

University of Sheffield

Newcastle University

Visiting Professor of Urology

Sheffield Hallam University

Adjunct Secretary responsible for Education

European Association of Urology

Sheffield

UK

Disclosures

CRC is Chairman of NICE Male LUTS Guidelines Development Group.

Professor of Urology

Institute of Cellular Medicine

Newcastle University

Newcastle upon Tyne

UK

Disclosures

RP has received funding from the UK NHS (NIHR) to undertake commissioned reviews of treatment for benign prostatic enlargement.

Chief

Department of Surgery

South Seminole Hospital

Longwood

FL

Disclosures

SKB is a member of the National Speakers Bureau for Boehringer Ingelheim, Astellas Pharmaceutics, and Glaxo Pharmaceuticals and has served as a consultant for these companies.

Use of this content is subject to our disclaimer